The Korea Research Institute of Standards and Science (KRISS) has developed the world's first organoid culture method capable of accurately assessing human toxicity of nanomaterials. Overcoming the limitations of the conventional culture method, this new technology is expected to bring forward the commercialization of organoid-based safety assessment of nanomaterials and nanomedicine.
